Glycine contributes to the stability and function of glutathione, helping it to perform its antioxidant duties effectively
A Dual-Action Treatment Tirzepatide is known as a dual agonist because it works on two hormone pathways in the body: GLP-1 and GIP
However, thousands have suffered dearly after taking this GLP-1 injection, which landed them in the hospital for blindness, pancreatitis, gastroparesis, and other complications
How GLP-1s cause weight loss There are three GLP-1 agonists approved in the last few years for the treatment of obesity: tirzepatide (Zepbound), semaglutide (Wegovy), and liraglutide (Saxenda)
When they later begin tirzepatide, there may be a period of overlap while tirzepatide titrates up to therapeutic levels